fanta.bio Sample: CNhs11868
18577 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1117 / 14484 (7.7%) | 375 / 144840 (0.3%) | −324.0 | −324.0 | 29.79 |
| HIF1A SRX11007095 | HK-2 Kidney | 2202 / 14484 (15.2%) | 807 / 144840 (0.6%) | −324.0 | −324.0 | 27.29 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1615 / 14484 (11.2%) | 686 / 144840 (0.5%) | −324.0 | −324.0 | 23.54 |
| TP53 SRX19538279 | Osteoblasts Bone | 515 / 14484 (3.6%) | 255 / 144840 (0.2%) | −324.0 | −324.0 | 20.20 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1477 / 14484 (10.2%) | 733 / 144840 (0.5%) | −324.0 | −324.0 | 20.15 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2106 / 14484 (14.5%) | 1058 / 144840 (0.7%) | −324.0 | −324.0 | 19.91 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2042 / 14484 (14.1%) | 1042 / 144840 (0.7%) | −324.0 | −324.0 | 19.60 |
| SCML2 SRX644728 | 293 Kidney | 1223 / 14484 (8.4%) | 707 / 144840 (0.5%) | −324.0 | −324.0 | 17.30 |
| FOXP1 SRX736067 | LNCAP Prostate | 1557 / 14484 (10.7%) | 1095 / 144840 (0.8%) | −324.0 | −324.0 | 14.22 |
| MYH11 SRX265221 | ME-1 Blood | 759 / 14484 (5.2%) | 564 / 144840 (0.4%) | −324.0 | −324.0 | 13.46 |
| BRD4 SRX9419935 | BT-474 Breast | 3133 / 14484 (21.6%) | 2544 / 144840 (1.8%) | −324.0 | −324.0 | 12.32 |
| BRD4 SRX9419937 | BT-474 Breast | 3108 / 14484 (21.5%) | 2613 / 144840 (1.8%) | −324.0 | −324.0 | 11.89 |
| MED1 SRX9419945 | BT-474 Breast | 3075 / 14484 (21.2%) | 2590 / 144840 (1.8%) | −324.0 | −324.0 | 11.87 |
| MED1 SRX9419944 | BT-474 Breast | 3008 / 14484 (20.8%) | 2545 / 144840 (1.8%) | −324.0 | −324.0 | 11.82 |
| MED1 SRX9419946 | BT-474 Breast | 3149 / 14484 (21.7%) | 2736 / 144840 (1.9%) | −324.0 | −324.0 | 11.51 |
| BRD4 SRX9419938 | BT-474 Breast | 3099 / 14484 (21.4%) | 2709 / 144840 (1.9%) | −324.0 | −324.0 | 11.44 |
| BRD4 SRX9419936 | BT-474 Breast | 3111 / 14484 (21.5%) | 2720 / 144840 (1.9%) | −324.0 | −324.0 | 11.44 |
| MED1 SRX9419947 | BT-474 Breast | 3028 / 14484 (20.9%) | 2699 / 144840 (1.9%) | −324.0 | −324.0 | 11.22 |
| EZH2 SRX2146136 | LNCAP Prostate | 6630 / 14484 (45.8%) | 7282 / 144840 (5.0%) | −324.0 | −324.0 | 9.10 |
| BRD4 SRX736201 | 90-8TL Neural | 5091 / 14484 (35.1%) | 6015 / 144840 (4.2%) | −324.0 | −324.0 | 8.46 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1608 / 14484 (11.1%) | 2389 / 144840 (1.6%) | −324.0 | −324.0 | 6.73 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1290 / 14484 (8.9%) | 3170 / 144840 (2.2%) | −324.0 | −324.0 | 4.07 |
| HIF1A SRX20663235 | HK-2 Kidney | 479 / 14484 (3.3%) | 231 / 144840 (0.2%) | −318.2 | −315.1 | 20.74 |
| TP53 SRX19538268 | U2OS Bone | 424 / 14484 (2.9%) | 157 / 144840 (0.1%) | −304.5 | −301.4 | 27.01 |
| PBX4 SRX2731658 | PC-3 Prostate | 783 / 14484 (5.4%) | 22813 / 144840 (15.8%) | −303.5 | −300.4 | 0.34 |
| TP53 SRX19538274 | U2OS Bone | 420 / 14484 (2.9%) | 165 / 144840 (0.1%) | −296.7 | −293.6 | 25.45 |
| TP53 SRX19538276 | U2OS Bone | 419 / 14484 (2.9%) | 167 / 144840 (0.1%) | −294.8 | −291.7 | 25.09 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1460 / 14484 (10.1%) | 4366 / 144840 (3.0%) | −293.5 | −290.5 | 3.34 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 639 / 14484 (4.4%) | 814 / 144840 (0.6%) | −272.3 | −269.2 | 7.85 |
| TP53 SRX19538280 | Osteoblasts Bone | 408 / 14484 (2.8%) | 197 / 144840 (0.1%) | −270.8 | −267.7 | 20.71 |
| IRF3 SRX11453858 | Hep G2 Liver | 326 / 14484 (2.3%) | 64 / 144840 (0.0%) | −269.2 | −266.2 | 50.94 |
| TP53 SRX19538267 | U2OS Bone | 377 / 14484 (2.6%) | 143 / 144840 (0.1%) | −268.9 | −265.9 | 26.36 |
| TP53 SRX19538275 | U2OS Bone | 372 / 14484 (2.6%) | 160 / 144840 (0.1%) | −255.9 | −252.9 | 23.25 |
| TP53 SRX19538273 | U2OS Bone | 365 / 14484 (2.5%) | 149 / 144840 (0.1%) | −255.0 | −252.0 | 24.50 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 397 / 14484 (2.7%) | 213 / 144840 (0.1%) | −254.3 | −251.3 | 18.64 |
| TP53 SRX19538281 | Osteoblasts Bone | 421 / 14484 (2.9%) | 275 / 144840 (0.2%) | −250.6 | −247.6 | 15.31 |
| AGO2 SRX4708039 | Hep G2 Liver | 1678 / 14484 (11.6%) | 6381 / 144840 (4.4%) | −238.5 | −235.5 | 2.63 |
| TP53 SRX19538269 | U2OS Bone | 444 / 14484 (3.1%) | 380 / 144840 (0.3%) | −234.9 | −232.0 | 11.68 |
| YAP1 SRX757325 | H2052 Lung | 593 / 14484 (4.1%) | 17661 / 144840 (12.2%) | −234.8 | −231.8 | 0.34 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 590 / 14484 (4.1%) | 845 / 144840 (0.6%) | −232.5 | −229.5 | 6.98 |
| FOS SRX150478 | MCF 10A Breast | 589 / 14484 (4.1%) | 17444 / 144840 (12.0%) | −230.0 | −227.1 | 0.34 |
| FOS SRX150477 | MCF 10A Breast | 562 / 14484 (3.9%) | 16987 / 144840 (11.7%) | −229.1 | −226.2 | 0.33 |
| IRF3 SRX11453861 | Hep G2 Liver | 286 / 14484 (2.0%) | 67 / 144840 (0.0%) | −228.4 | −225.6 | 42.69 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 510 / 14484 (3.5%) | 16090 / 144840 (11.1%) | −227.0 | −224.1 | 0.32 |
| FOXA1 SRX4815198 | MCF-7 Breast | 822 / 14484 (5.7%) | 20810 / 144840 (14.4%) | −225.6 | −222.7 | 0.40 |
| KAT6A SRX20971022 | Fibroblasts Others | 272 / 14484 (1.9%) | 58 / 144840 (0.0%) | −221.2 | −218.4 | 46.90 |
| YAP1 SRX757326 | H2052 Lung | 507 / 14484 (3.5%) | 15816 / 144840 (10.9%) | −219.9 | −217.1 | 0.32 |
| TP53 SRX19538270 | U2OS Bone | 421 / 14484 (2.9%) | 383 / 144840 (0.3%) | −216.2 | −213.3 | 10.99 |
| FOXA1 SRX4815197 | MCF-7 Breast | 606 / 14484 (4.2%) | 17090 / 144840 (11.8%) | −211.4 | −208.6 | 0.35 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 556 / 14484 (3.8%) | 877 / 144840 (0.6%) | −204.3 | −201.5 | 6.34 |
| ESR1 SRX4367193 | MCF-7 Breast | 853 / 14484 (5.9%) | 20399 / 144840 (14.1%) | −201.5 | −198.7 | 0.42 |
| FOXA1 SRX176862 | MCF-7 Breast | 306 / 14484 (2.1%) | 11863 / 144840 (8.2%) | −201.5 | −198.7 | 0.26 |
| FOS SRX4192880 | MCF 10A Breast | 425 / 14484 (2.9%) | 13771 / 144840 (9.5%) | −197.7 | −194.9 | 0.31 |
| BRD4 SRX736204 | 90-8TL Neural | 892 / 14484 (6.2%) | 2433 / 144840 (1.7%) | −197.5 | −194.7 | 3.67 |
| AR SRX10820653 | LNCAP Prostate | 312 / 14484 (2.2%) | 175 / 144840 (0.1%) | −196.6 | −193.8 | 17.83 |
| TP53 SRX19538282 | Osteoblasts Bone | 361 / 14484 (2.5%) | 302 / 144840 (0.2%) | −193.0 | −190.2 | 11.95 |
| ESR1 SRX7624157 | MCF-7 Breast | 692 / 14484 (4.8%) | 17675 / 144840 (12.2%) | −190.9 | −188.1 | 0.39 |
| TP53 SRX19538271 | U2OS Bone | 590 / 14484 (4.1%) | 1094 / 144840 (0.8%) | −190.8 | −188.1 | 5.39 |
| FOXA1 SRX3931044 | MCF-7 Breast | 567 / 14484 (3.9%) | 15776 / 144840 (10.9%) | −190.4 | −187.7 | 0.36 |
| ESR1 SRX371478 | MCF-7 Breast | 327 / 14484 (2.3%) | 11836 / 144840 (8.2%) | −188.7 | −186.0 | 0.28 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 172 / 14484 (1.2%) | 8836 / 144840 (6.1%) | −183.6 | −180.9 | 0.19 |
| JUNB SRX8488088 | SUM 229PE Breast | 519 / 14484 (3.6%) | 14768 / 144840 (10.2%) | −182.6 | −179.9 | 0.35 |
| FOXA1 SRX176863 | MCF-7 Breast | 308 / 14484 (2.1%) | 11294 / 144840 (7.8%) | −181.9 | −179.1 | 0.27 |
| GATA3 SRX190239 | MCF-7 Breast | 383 / 14484 (2.6%) | 12566 / 144840 (8.7%) | −181.8 | −179.1 | 0.30 |
| ESR1 SRX7624156 | MCF-7 Breast | 430 / 14484 (3.0%) | 13330 / 144840 (9.2%) | −181.7 | −179.0 | 0.32 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 316 / 14484 (2.2%) | 11414 / 144840 (7.9%) | −181.2 | −178.5 | 0.28 |
| FOXA1 SRX371482 | MCF-7 Breast | 383 / 14484 (2.6%) | 12464 / 144840 (8.6%) | −178.8 | −176.1 | 0.31 |
| ESR1 SRX20282961 | MCF-7 Breast | 335 / 14484 (2.3%) | 11655 / 144840 (8.0%) | −178.6 | −176.0 | 0.29 |
| AR SRX1067071 | LHSAR Prostate | 537 / 14484 (3.7%) | 14876 / 144840 (10.3%) | −177.6 | −174.9 | 0.36 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 306 / 14484 (2.1%) | 11078 / 144840 (7.6%) | −176.0 | −173.3 | 0.28 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 338 / 14484 (2.3%) | 11615 / 144840 (8.0%) | −175.8 | −173.1 | 0.29 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 652 / 14484 (4.5%) | 16518 / 144840 (11.4%) | −175.1 | −172.5 | 0.39 |
| BRD1 SRX286203 | RKO Digestive tract | 1041 / 14484 (7.2%) | 3512 / 144840 (2.4%) | −174.8 | −172.2 | 2.96 |
| FOXA1 SRX371481 | MCF-7 Breast | 278 / 14484 (1.9%) | 10528 / 144840 (7.3%) | −174.1 | −171.4 | 0.26 |
| FOXA1 SRX371483 | MCF-7 Breast | 300 / 14484 (2.1%) | 10903 / 144840 (7.5%) | −173.8 | −171.2 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 313 / 14484 (2.2%) | 11112 / 144840 (7.7%) | −173.3 | −170.7 | 0.28 |
| FOXA1 SRX1161177 | MCF-7 Breast | 268 / 14484 (1.9%) | 10300 / 144840 (7.1%) | −172.5 | −169.8 | 0.26 |
| ESR1 SRX371469 | MCF-7 Breast | 281 / 14484 (1.9%) | 10515 / 144840 (7.3%) | −172.0 | −169.3 | 0.27 |
| KAT7 SRX101303 | RKO Digestive tract | 1180 / 14484 (8.1%) | 4374 / 144840 (3.0%) | −171.9 | −169.3 | 2.70 |
| RUNX1 SRX2513054 | 293 Kidney | 2731 / 14484 (18.9%) | 15294 / 144840 (10.6%) | −171.9 | −169.3 | 1.79 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1219 / 14484 (8.4%) | 4616 / 144840 (3.2%) | −171.7 | −169.0 | 2.64 |
| TLE3 SRX4815191 | MCF-7 Breast | 253 / 14484 (1.7%) | 9993 / 144840 (6.9%) | −171.2 | −168.6 | 0.25 |
| Epitope tags SRX10549776 | K-562 Blood | 1198 / 14484 (8.3%) | 4504 / 144840 (3.1%) | −170.6 | −168.0 | 2.66 |
| FOS SRX150517 | MCF 10A Breast | 481 / 14484 (3.3%) | 13761 / 144840 (9.5%) | −170.5 | −167.9 | 0.35 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 476 / 14484 (3.3%) | 13683 / 144840 (9.4%) | −170.4 | −167.8 | 0.35 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 396 / 14484 (2.7%) | 12355 / 144840 (8.5%) | −169.0 | −166.4 | 0.32 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1773 / 14484 (12.2%) | 8320 / 144840 (5.7%) | −168.3 | −165.7 | 2.13 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 246 / 14484 (1.7%) | 109 / 144840 (0.1%) | −167.7 | −165.1 | 22.57 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 690 / 14484 (4.8%) | 16802 / 144840 (11.6%) | −167.7 | −165.1 | 0.41 |
| BRPF3 SRX796085 | RKO Digestive tract | 943 / 14484 (6.5%) | 3057 / 144840 (2.1%) | −167.1 | −164.6 | 3.08 |
| ESR1 SRX176860 | MCF-7 Breast | 474 / 14484 (3.3%) | 13529 / 144840 (9.3%) | −167.0 | −164.4 | 0.35 |
| AGO2 SRX6783957 | Hep G2 Liver | 1078 / 14484 (7.4%) | 3850 / 144840 (2.7%) | −166.2 | −163.6 | 2.80 |
| ESR1 SRX371479 | MCF-7 Breast | 254 / 14484 (1.8%) | 9829 / 144840 (6.8%) | −165.2 | −162.7 | 0.26 |
| FOS SRX150476 | MCF 10A Breast | 498 / 14484 (3.4%) | 13823 / 144840 (9.5%) | −164.6 | −162.1 | 0.36 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 412 / 14484 (2.8%) | 12460 / 144840 (8.6%) | −164.3 | −161.7 | 0.33 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 688 / 14484 (4.8%) | 16634 / 144840 (11.5%) | −163.9 | −161.4 | 0.41 |
| AGO2 SRX6783958 | Hep G2 Liver | 1058 / 14484 (7.3%) | 3768 / 144840 (2.6%) | −163.7 | −161.2 | 2.81 |
| TP53 SRX396254 | Fibroblasts Others | 795 / 14484 (5.5%) | 2298 / 144840 (1.6%) | −163.6 | −161.1 | 3.46 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 630 / 14484 (4.3%) | 15770 / 144840 (10.9%) | −163.5 | −160.9 | 0.40 |
| AR SRX1067070 | LHSAR Prostate | 712 / 14484 (4.9%) | 16950 / 144840 (11.7%) | −163.1 | −160.6 | 0.42 |
| AR SRX10820651 | LNCAP Prostate | 308 / 14484 (2.1%) | 266 / 144840 (0.2%) | −162.2 | −159.6 | 11.58 |
| BRPF3 SRX796086 | RKO Digestive tract | 1248 / 14484 (8.6%) | 4952 / 144840 (3.4%) | −162.1 | −159.6 | 2.52 |
| ESR1 SRX20282960 | MCF-7 Breast | 328 / 14484 (2.3%) | 10991 / 144840 (7.6%) | −161.5 | −159.0 | 0.30 |
| ESR1 SRX371471 | ZR-75-1 Breast | 312 / 14484 (2.2%) | 10669 / 144840 (7.4%) | −159.9 | −157.4 | 0.29 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1063 / 14484 (7.3%) | 21668 / 144840 (15.0%) | −159.6 | −157.1 | 0.49 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 501 / 14484 (3.5%) | 13679 / 144840 (9.4%) | −159.2 | −156.7 | 0.37 |
| YAP1 SRX5718140 | 293 Kidney | 492 / 14484 (3.4%) | 13539 / 144840 (9.3%) | −159.1 | −156.6 | 0.36 |
| ESR1 SRX371470 | ZR-75-1 Breast | 258 / 14484 (1.8%) | 9707 / 144840 (6.7%) | −158.9 | −156.4 | 0.27 |
| ESR1 SRX176861 | MCF-7 Breast | 490 / 14484 (3.4%) | 13443 / 144840 (9.3%) | −157.3 | −154.9 | 0.36 |
| BRPF3 SRX796084 | RKO Digestive tract | 1275 / 14484 (8.8%) | 5216 / 144840 (3.6%) | −156.8 | −154.3 | 2.44 |
| JUN SRX17561461 | LPS141 Adipocyte | 417 / 14484 (2.9%) | 12273 / 144840 (8.5%) | −156.4 | −154.0 | 0.34 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 572 / 14484 (3.9%) | 14649 / 144840 (10.1%) | −156.2 | −153.8 | 0.39 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1008 / 14484 (7.0%) | 20767 / 144840 (14.3%) | −155.7 | −153.2 | 0.49 |
| ESR1 SRX20282939 | MCF-7 Breast | 337 / 14484 (2.3%) | 10952 / 144840 (7.6%) | −155.6 | −153.2 | 0.31 |
| FOXA1 SRX1161176 | MCF-7 Breast | 278 / 14484 (1.9%) | 9936 / 144840 (6.9%) | −155.1 | −152.6 | 0.28 |
| FOXA1 SRX100454 | T-47D Breast | 373 / 14484 (2.6%) | 11522 / 144840 (8.0%) | −155.1 | −152.6 | 0.32 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 301 / 14484 (2.1%) | 10325 / 144840 (7.1%) | −155.0 | −152.6 | 0.29 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 375 / 14484 (2.6%) | 11544 / 144840 (8.0%) | −154.8 | −152.3 | 0.32 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 255 / 14484 (1.8%) | 9524 / 144840 (6.6%) | −154.8 | −152.3 | 0.27 |
| JUNB SRX8488073 | SUM 229PE Breast | 560 / 14484 (3.9%) | 14372 / 144840 (9.9%) | −153.6 | −151.2 | 0.39 |
| FOXA1 SRX1161173 | MCF-7 Breast | 227 / 14484 (1.6%) | 8981 / 144840 (6.2%) | −153.3 | −150.8 | 0.25 |
| ESR1 SRX371467 | MCF-7 Breast | 309 / 14484 (2.1%) | 10403 / 144840 (7.2%) | −153.2 | −150.7 | 0.30 |
| ESR1 SRX194569 | MCF-7 Breast | 308 / 14484 (2.1%) | 10374 / 144840 (7.2%) | −152.9 | −150.5 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 278 / 14484 (1.9%) | 9865 / 144840 (6.8%) | −152.9 | −150.5 | 0.28 |
| SMARCA2 SRX8119677 | MeT-5A Others | 488 / 14484 (3.4%) | 13253 / 144840 (9.2%) | −152.7 | −150.3 | 0.37 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 642 / 14484 (4.4%) | 15537 / 144840 (10.7%) | −152.4 | −150.0 | 0.41 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 395 / 14484 (2.7%) | 582 / 144840 (0.4%) | −152.2 | −149.8 | 6.79 |
| ESR1 SRX4367192 | MCF-7 Breast | 618 / 14484 (4.3%) | 15171 / 144840 (10.5%) | −152.1 | −149.6 | 0.41 |
| FOXA1 SRX1161175 | MCF-7 Breast | 210 / 14484 (1.4%) | 8620 / 144840 (6.0%) | −151.7 | −149.3 | 0.24 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1012 / 14484 (7.0%) | 20608 / 144840 (14.2%) | −150.5 | −148.1 | 0.49 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 256 / 14484 (1.8%) | 9407 / 144840 (6.5%) | −150.4 | −148.0 | 0.27 |
| FOS SRX4192879 | MCF 10A Breast | 341 / 14484 (2.4%) | 10826 / 144840 (7.5%) | −149.9 | −147.5 | 0.31 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1172 / 14484 (8.1%) | 22676 / 144840 (15.7%) | −149.4 | −147.1 | 0.52 |
| ESR1 SRX194572 | MCF-7 Breast | 179 / 14484 (1.2%) | 7969 / 144840 (5.5%) | −149.2 | −146.8 | 0.22 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 264 / 14484 (1.8%) | 9502 / 144840 (6.6%) | −149.1 | −146.7 | 0.28 |
| FOXA1 SRX11222441 | MCF-7 Breast | 215 / 14484 (1.5%) | 8629 / 144840 (6.0%) | −148.9 | −146.5 | 0.25 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 264 / 14484 (1.8%) | 9493 / 144840 (6.6%) | −148.8 | −146.4 | 0.28 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 581 / 14484 (4.0%) | 14501 / 144840 (10.0%) | −148.6 | −146.2 | 0.40 |
| ESR1 SRX371476 | MCF-7 Breast | 220 / 14484 (1.5%) | 8699 / 144840 (6.0%) | −148.3 | −145.9 | 0.25 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 297 / 14484 (2.1%) | 10032 / 144840 (6.9%) | −148.1 | −145.7 | 0.30 |
| STAT3 SRX2020842 | HCC70 Breast | 536 / 14484 (3.7%) | 13801 / 144840 (9.5%) | −147.8 | −145.4 | 0.39 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 263 / 14484 (1.8%) | 9429 / 144840 (6.5%) | −147.4 | −145.0 | 0.28 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 269 / 14484 (1.9%) | 9528 / 144840 (6.6%) | −147.3 | −144.9 | 0.28 |
| ESR1 SRX1531791 | MCF-7 Breast | 295 / 14484 (2.0%) | 9974 / 144840 (6.9%) | −147.3 | −144.9 | 0.30 |
| FOXA1 SRX1161174 | MCF-7 Breast | 303 / 14484 (2.1%) | 10104 / 144840 (7.0%) | −147.2 | −144.8 | 0.30 |
| TCF12 SRX190356 | SK-N-SH Neural | 839 / 14484 (5.8%) | 18106 / 144840 (12.5%) | −146.8 | −144.4 | 0.46 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1468 / 14484 (10.1%) | 6712 / 144840 (4.6%) | −145.7 | −143.4 | 2.19 |
| GATA3 SRX190194 | SK-N-SH Neural | 728 / 14484 (5.0%) | 16508 / 144840 (11.4%) | −145.7 | −143.3 | 0.44 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 504 / 14484 (3.5%) | 13238 / 144840 (9.1%) | −145.6 | −143.2 | 0.38 |
| ESR1 SRX371468 | MCF-7 Breast | 187 / 14484 (1.3%) | 8008 / 144840 (5.5%) | −145.5 | −143.1 | 0.23 |
| SMARCA4 SRX5212366 | Mel270 Others | 408 / 14484 (2.8%) | 11736 / 144840 (8.1%) | −145.0 | −142.7 | 0.35 |
| FOXA1 SRX371480 | MCF-7 Breast | 200 / 14484 (1.4%) | 8233 / 144840 (5.7%) | −145.0 | −142.6 | 0.24 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 227 / 14484 (1.6%) | 8715 / 144840 (6.0%) | −144.8 | −142.5 | 0.26 |
| GATA3 SRX176864 | MCF-7 Breast | 217 / 14484 (1.5%) | 8537 / 144840 (5.9%) | −144.8 | −142.4 | 0.25 |
| TP53 SRX19538272 | U2OS Bone | 491 / 14484 (3.4%) | 1010 / 144840 (0.7%) | −144.7 | −142.4 | 4.86 |
| JUN SRX4192884 | MCF 10A Breast | 246 / 14484 (1.7%) | 9042 / 144840 (6.2%) | −144.4 | −142.1 | 0.27 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 279 / 14484 (1.9%) | 9608 / 144840 (6.6%) | −144.3 | −142.0 | 0.29 |
| SMARCA4 SRX5212357 | Mel270 Others | 441 / 14484 (3.0%) | 12216 / 144840 (8.4%) | −143.9 | −141.6 | 0.36 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 599 / 14484 (4.1%) | 14582 / 144840 (10.1%) | −143.7 | −141.4 | 0.41 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 264 / 14484 (1.8%) | 9329 / 144840 (6.4%) | −143.7 | −141.4 | 0.28 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 257 / 14484 (1.8%) | 9204 / 144840 (6.4%) | −143.5 | −141.2 | 0.28 |
| 5-mC SRX882970 | LNCAP Prostate | 2360 / 14484 (16.3%) | 13293 / 144840 (9.2%) | −143.2 | −140.9 | 1.78 |
| CEBPB SRX150632 | HeLa Uterus | 712 / 14484 (4.9%) | 16180 / 144840 (11.2%) | −143.0 | −140.7 | 0.44 |
| ESR1 SRX20282954 | MCF-7 Breast | 344 / 14484 (2.4%) | 10643 / 144840 (7.3%) | −143.0 | −140.7 | 0.32 |
| ARID1A SRX5089376 | MCF-7 Breast | 253 / 14484 (1.7%) | 9118 / 144840 (6.3%) | −142.9 | −140.6 | 0.28 |
| ARID5B SRX3230377 | Hep G2 Liver | 769 / 14484 (5.3%) | 16953 / 144840 (11.7%) | −142.4 | −140.1 | 0.45 |
| FOXA1 SRX1787653 | MCF-7 Breast | 240 / 14484 (1.7%) | 8869 / 144840 (6.1%) | −142.4 | −140.1 | 0.27 |
| VGLL1 SRX24602130 | BT-20 Breast | 314 / 14484 (2.2%) | 10128 / 144840 (7.0%) | −142.4 | −140.1 | 0.31 |
| TEAD1 SRX3401272 | MCF-7 Breast | 221 / 14484 (1.5%) | 8524 / 144840 (5.9%) | −142.0 | −139.7 | 0.26 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 300 / 14484 (2.1%) | 9878 / 144840 (6.8%) | −141.8 | −139.5 | 0.30 |
| ESR1 SRX2943591 | MCF-7 Breast | 204 / 14484 (1.4%) | 8198 / 144840 (5.7%) | −141.4 | −139.1 | 0.25 |
| NR2F2 SRX190293 | MCF-7 Breast | 322 / 14484 (2.2%) | 10230 / 144840 (7.1%) | −141.4 | −139.1 | 0.31 |
| SMARCA4 SRX5212362 | Mel270 Others | 540 / 14484 (3.7%) | 13608 / 144840 (9.4%) | −141.0 | −138.7 | 0.40 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 533 / 14484 (3.7%) | 1228 / 144840 (0.8%) | −140.9 | −138.6 | 4.34 |
| NKX2-1 SRX2164786 | A549 Lung | 510 / 14484 (3.5%) | 13153 / 144840 (9.1%) | −140.7 | −138.4 | 0.39 |
| ESR1 SRX20282973 | MCF-7 Breast | 380 / 14484 (2.6%) | 11130 / 144840 (7.7%) | −140.3 | −138.0 | 0.34 |
| CIC SRX13262055 | Astrocytes Neural | 2480 / 14484 (17.1%) | 14324 / 144840 (9.9%) | −140.1 | −137.8 | 1.73 |
| JUNB SRX8488089 | SUM 229PE Breast | 310 / 14484 (2.1%) | 9971 / 144840 (6.9%) | −139.6 | −137.4 | 0.31 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 401 / 14484 (2.8%) | 682 / 144840 (0.5%) | −138.9 | −136.6 | 5.88 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 435 / 14484 (3.0%) | 11938 / 144840 (8.2%) | −138.8 | −136.5 | 0.36 |
| FOXA2 SRX3230382 | Hep G2 Liver | 419 / 14484 (2.9%) | 11689 / 144840 (8.1%) | −138.7 | −136.4 | 0.36 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 326 / 14484 (2.3%) | 10205 / 144840 (7.0%) | −138.6 | −136.4 | 0.32 |
| FOXA1 SRX11222442 | MCF-7 Breast | 195 / 14484 (1.3%) | 7941 / 144840 (5.5%) | −138.4 | −136.1 | 0.25 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 958 / 14484 (6.6%) | 3558 / 144840 (2.5%) | −138.1 | −135.8 | 2.69 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 938 / 14484 (6.5%) | 19076 / 144840 (13.2%) | −137.8 | −135.5 | 0.49 |
| ESR1 SRX20282940 | MCF-7 Breast | 342 / 14484 (2.4%) | 10426 / 144840 (7.2%) | −137.6 | −135.3 | 0.33 |
| 5-mC SRX882968 | LNCAP Prostate | 2321 / 14484 (16.0%) | 13170 / 144840 (9.1%) | −137.4 | −135.2 | 1.76 |
| FOXA1 SRX3923514 | MCF-7 Breast | 322 / 14484 (2.2%) | 10091 / 144840 (7.0%) | −137.3 | −135.0 | 0.32 |
| JUNB SRX10119386 | MCF 10A Breast | 279 / 14484 (1.9%) | 9379 / 144840 (6.5%) | −137.3 | −135.0 | 0.30 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 279 / 14484 (1.9%) | 9379 / 144840 (6.5%) | −137.3 | −135.0 | 0.30 |
| ING5 SRX286202 | RKO Digestive tract | 1099 / 14484 (7.6%) | 4451 / 144840 (3.1%) | −136.9 | −134.6 | 2.47 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 209 / 14484 (1.4%) | 8128 / 144840 (5.6%) | −136.2 | −133.9 | 0.26 |
| STAT5B SRX831881 | CD8+ T cells Blood | 226 / 14484 (1.6%) | 144 / 144840 (0.1%) | −135.9 | −133.6 | 15.69 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 141 / 14484 (1.0%) | 6832 / 144840 (4.7%) | −135.4 | −133.1 | 0.21 |
| JUNB SRX8488074 | SUM 229PE Breast | 424 / 14484 (2.9%) | 11646 / 144840 (8.0%) | −135.3 | −133.1 | 0.36 |
| ARID1A SRX5089379 | MCF-7 Breast | 303 / 14484 (2.1%) | 9702 / 144840 (6.7%) | −135.0 | −132.8 | 0.31 |
| ESR1 SRX20282972 | MCF-7 Breast | 366 / 14484 (2.5%) | 10720 / 144840 (7.4%) | −134.9 | −132.7 | 0.34 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1017 / 14484 (7.0%) | 20008 / 144840 (13.8%) | −134.8 | −132.6 | 0.51 |
| BMI1 SRX644729 | 293 Kidney | 222 / 14484 (1.5%) | 138 / 144840 (0.1%) | −134.8 | −132.5 | 16.09 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 288 / 14484 (2.0%) | 9441 / 144840 (6.5%) | −134.6 | −132.4 | 0.31 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 676 / 14484 (4.7%) | 2003 / 144840 (1.4%) | −134.4 | −132.2 | 3.37 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 234 / 14484 (1.6%) | 8508 / 144840 (5.9%) | −134.2 | −131.9 | 0.28 |
| SMARCA4 SRX5212371 | Mel270 Others | 454 / 14484 (3.1%) | 12065 / 144840 (8.3%) | −134.1 | −131.9 | 0.38 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 839 / 14484 (5.8%) | 17580 / 144840 (12.1%) | −134.0 | −131.7 | 0.48 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 409 / 14484 (2.8%) | 11366 / 144840 (7.8%) | −133.9 | −131.7 | 0.36 |
| RELA SRX5938177 | FaDu Others | 287 / 14484 (2.0%) | 9400 / 144840 (6.5%) | −133.8 | −131.6 | 0.31 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 218 / 14484 (1.5%) | 8210 / 144840 (5.7%) | −133.8 | −131.6 | 0.27 |
| ESR1 SRX10365535 | MCF-7 Breast | 259 / 14484 (1.8%) | 8926 / 144840 (6.2%) | −133.8 | −131.6 | 0.29 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 575 / 14484 (4.0%) | 1494 / 144840 (1.0%) | −133.7 | −131.5 | 3.85 |
| TRP47 SRX4548329 | THP-1 Blood | 2148 / 14484 (14.8%) | 11961 / 144840 (8.3%) | −133.4 | −131.3 | 1.80 |
| GATA3 SRX5057632 | MCF-7 Breast | 204 / 14484 (1.4%) | 7949 / 144840 (5.5%) | −133.4 | −131.2 | 0.26 |
| PGR SRX1012655 | MCF-7 Breast | 190 / 14484 (1.3%) | 7698 / 144840 (5.3%) | −133.3 | −131.1 | 0.25 |
| FOXA1 SRX11222437 | MCF-7 Breast | 221 / 14484 (1.5%) | 8253 / 144840 (5.7%) | −133.3 | −131.1 | 0.27 |
| WWTR1 SRX10119367 | MCF 10A Breast | 370 / 14484 (2.6%) | 10725 / 144840 (7.4%) | −133.1 | −130.9 | 0.34 |
| GATAD2A SRX2636506 | Hep G2 Liver | 408 / 14484 (2.8%) | 11315 / 144840 (7.8%) | −133.0 | −130.8 | 0.36 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 922 / 14484 (6.4%) | 18653 / 144840 (12.9%) | −132.8 | −130.6 | 0.49 |
| ESR1 SRX20282955 | MCF-7 Breast | 345 / 14484 (2.4%) | 10298 / 144840 (7.1%) | −132.3 | −130.1 | 0.34 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 346 / 14484 (2.4%) | 10307 / 144840 (7.1%) | −132.2 | −130.0 | 0.34 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 248 / 14484 (1.7%) | 8668 / 144840 (6.0%) | −131.7 | −129.5 | 0.29 |
| JUNB SRX4192882 | MCF 10A Breast | 252 / 14484 (1.7%) | 8738 / 144840 (6.0%) | −131.7 | −129.5 | 0.29 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 562 / 14484 (3.9%) | 13564 / 144840 (9.4%) | −131.1 | −128.9 | 0.41 |
| ESR1 SRX2881002 | MCF-7 Breast | 309 / 14484 (2.1%) | 9670 / 144840 (6.7%) | −131.1 | −128.9 | 0.32 |
| AR SRX9109110 | MDA-MB-453 Breast | 614 / 14484 (4.2%) | 14307 / 144840 (9.9%) | −130.9 | −128.7 | 0.43 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1576 / 14484 (10.9%) | 7802 / 144840 (5.4%) | −130.8 | −128.7 | 2.02 |
| FOXA1 SRX3931043 | MCF-7 Breast | 329 / 14484 (2.3%) | 9982 / 144840 (6.9%) | −130.7 | −128.5 | 0.33 |
| ESR1 SRX20282946 | MCF-7 Breast | 188 / 14484 (1.3%) | 7577 / 144840 (5.2%) | −130.7 | −128.5 | 0.25 |
| SOX13 SRX2636248 | Hep G2 Liver | 442 / 14484 (3.1%) | 11747 / 144840 (8.1%) | −130.5 | −128.3 | 0.38 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 269 / 14484 (1.9%) | 8987 / 144840 (6.2%) | −130.5 | −128.3 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 511 / 14484 (3.5%) | 12771 / 144840 (8.8%) | −130.1 | −127.9 | 0.40 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 291 / 14484 (2.0%) | 9330 / 144840 (6.4%) | −129.8 | −127.6 | 0.31 |
| AR SRX1067067 | LHSAR Prostate | 563 / 14484 (3.9%) | 13510 / 144840 (9.3%) | −129.4 | −127.2 | 0.42 |
| PRRX1 SRX15235713 | Hs 578T Breast | 398 / 14484 (2.7%) | 11031 / 144840 (7.6%) | −129.4 | −127.2 | 0.36 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 301 / 14484 (2.1%) | 9481 / 144840 (6.5%) | −129.3 | −127.1 | 0.32 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 415 / 14484 (2.9%) | 11284 / 144840 (7.8%) | −129.0 | −126.9 | 0.37 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 234 / 14484 (1.6%) | 8341 / 144840 (5.8%) | −129.0 | −126.8 | 0.28 |
| FOS SRX3322636 | MCF-7 Breast | 204 / 14484 (1.4%) | 7813 / 144840 (5.4%) | −128.9 | −126.8 | 0.26 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 428 / 14484 (3.0%) | 860 / 144840 (0.6%) | −128.8 | −126.7 | 4.98 |
| RAC1 SRX10365543 | MCF-7 Breast | 169 / 14484 (1.2%) | 7167 / 144840 (4.9%) | −128.7 | −126.6 | 0.24 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 199 / 14484 (1.4%) | 104 / 144840 (0.1%) | −128.7 | −126.5 | 19.13 |
| GATA3 SRX5457550 | MCF-7 Breast | 359 / 14484 (2.5%) | 10389 / 144840 (7.2%) | −128.6 | −126.4 | 0.35 |
| RAC1 SRX10365541 | MCF-7 Breast | 168 / 14484 (1.2%) | 7141 / 144840 (4.9%) | −128.5 | −126.4 | 0.24 |
| ESR1 SRX2881000 | MCF-7 Breast | 287 / 14484 (2.0%) | 9209 / 144840 (6.4%) | −128.2 | −126.0 | 0.31 |
| SREBF2 SRX5359048 | HCC70 Breast | 1393 / 14484 (9.6%) | 6581 / 144840 (4.5%) | −128.1 | −126.0 | 2.12 |
| TLE3 SRX4815192 | MCF-7 Breast | 294 / 14484 (2.0%) | 9320 / 144840 (6.4%) | −128.0 | −125.9 | 0.32 |
| ESR1 SRX371477 | MCF-7 Breast | 158 / 14484 (1.1%) | 6938 / 144840 (4.8%) | −128.0 | −125.8 | 0.23 |
| AR SRX9469988 | LAPC-4 Prostate | 447 / 14484 (3.1%) | 11729 / 144840 (8.1%) | −127.8 | −125.6 | 0.38 |
| FOXA1 SRX100506 | Hep G2 Liver | 433 / 14484 (3.0%) | 11514 / 144840 (7.9%) | −127.7 | −125.6 | 0.38 |
| ESR1 SRX10365536 | MCF-7 Breast | 173 / 14484 (1.2%) | 7208 / 144840 (5.0%) | −127.7 | −125.6 | 0.24 |
| ESR1 SRX5323873 | MCF-7 Breast | 403 / 14484 (2.8%) | 11048 / 144840 (7.6%) | −127.7 | −125.5 | 0.36 |
| ESR1 SRX330067 | MCF-7 Breast | 297 / 14484 (2.1%) | 9356 / 144840 (6.5%) | −127.6 | −125.4 | 0.32 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1150 / 14484 (7.9%) | 21414 / 144840 (14.8%) | −127.5 | −125.3 | 0.54 |
| AR SRX9109113 | MDA-MB-453 Breast | 637 / 14484 (4.4%) | 14491 / 144840 (10.0%) | −127.2 | −125.1 | 0.44 |
| JUNB SRX10119383 | MCF 10A Breast | 223 / 14484 (1.5%) | 8077 / 144840 (5.6%) | −126.7 | −124.6 | 0.28 |
| ESR1 SRX371475 | BT-474 Breast | 161 / 14484 (1.1%) | 6955 / 144840 (4.8%) | −126.7 | −124.5 | 0.23 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 606 / 14484 (4.2%) | 14024 / 144840 (9.7%) | −126.6 | −124.5 | 0.43 |
| JUND SRX150408 | HeLa Uterus | 287 / 14484 (2.0%) | 9156 / 144840 (6.3%) | −126.5 | −124.4 | 0.31 |
| ARID1A SRX5089385 | MCF-7 Breast | 236 / 14484 (1.6%) | 8291 / 144840 (5.7%) | −126.4 | −124.3 | 0.28 |
| STAT3 SRX150479 | MCF 10A Breast | 306 / 14484 (2.1%) | 9466 / 144840 (6.5%) | −126.4 | −124.3 | 0.32 |
| YAP1 SRX10119364 | MCF 10A Breast | 273 / 14484 (1.9%) | 8918 / 144840 (6.2%) | −126.4 | −124.3 | 0.31 |
| STAT3 SRX150536 | MCF 10A Breast | 371 / 14484 (2.6%) | 10495 / 144840 (7.2%) | −126.1 | −124.0 | 0.35 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 335 / 14484 (2.3%) | 9925 / 144840 (6.9%) | −126.1 | −124.0 | 0.34 |
| ESR1 SRX20282971 | MCF-7 Breast | 330 / 14484 (2.3%) | 9839 / 144840 (6.8%) | −126.0 | −123.9 | 0.34 |
| STAT3 SRX150630 | MCF 10A Breast | 304 / 14484 (2.1%) | 9409 / 144840 (6.5%) | −125.8 | −123.7 | 0.32 |
| ESR1 SRX20282953 | MCF-7 Breast | 271 / 14484 (1.9%) | 8864 / 144840 (6.1%) | −125.8 | −123.7 | 0.31 |
| DAXX SRX1021630 | PC-3 Prostate | 328 / 14484 (2.3%) | 9795 / 144840 (6.8%) | −125.6 | −123.5 | 0.33 |
| SP1 SRX190358 | HCT 116 Digestive tract | 502 / 14484 (3.5%) | 12449 / 144840 (8.6%) | −125.1 | −123.0 | 0.40 |
| FOXA1 SRX1161203 | T-47D Breast | 229 / 14484 (1.6%) | 8123 / 144840 (5.6%) | −125.0 | −122.9 | 0.28 |
| ARID5B SRX10475139 | Hep G2 Liver | 359 / 14484 (2.5%) | 10261 / 144840 (7.1%) | −124.9 | −122.8 | 0.35 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 377 / 14484 (2.6%) | 10536 / 144840 (7.3%) | −124.6 | −122.6 | 0.36 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 510 / 14484 (3.5%) | 1266 / 144840 (0.9%) | −124.6 | −122.5 | 4.03 |
| EP300 SRX150579 | HeLa Uterus | 221 / 14484 (1.5%) | 7975 / 144840 (5.5%) | −124.6 | −122.5 | 0.28 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 501 / 14484 (3.5%) | 12417 / 144840 (8.6%) | −124.5 | −122.5 | 0.40 |
| ESR1 SRX3110725 | MCF-7 Breast | 301 / 14484 (2.1%) | 9313 / 144840 (6.4%) | −124.3 | −122.2 | 0.32 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1335 / 14484 (9.2%) | 6269 / 144840 (4.3%) | −124.2 | −122.1 | 2.13 |
| EP300 SRX1012648 | MCF-7 Breast | 148 / 14484 (1.0%) | 6625 / 144840 (4.6%) | −123.8 | −121.7 | 0.22 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 321 / 14484 (2.2%) | 9611 / 144840 (6.6%) | −123.6 | −121.6 | 0.33 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 964 / 14484 (6.7%) | 18811 / 144840 (13.0%) | −123.6 | −121.5 | 0.51 |
| FOXA1 SRX028634 | MCF-7 Breast | 160 / 14484 (1.1%) | 6834 / 144840 (4.7%) | −123.3 | −121.2 | 0.23 |
| ESR1 SRX371474 | BT-474 Breast | 146 / 14484 (1.0%) | 6571 / 144840 (4.5%) | −123.2 | −121.2 | 0.22 |
| FOXA1 SRX1787652 | MCF-7 Breast | 200 / 14484 (1.4%) | 7558 / 144840 (5.2%) | −123.2 | −121.1 | 0.26 |
| ZEB1 SRX13298925 | MCF-7 Breast | 196 / 14484 (1.4%) | 7473 / 144840 (5.2%) | −122.7 | −120.6 | 0.26 |
| ESR1 SRX8537722 | MCF-7 Breast | 315 / 14484 (2.2%) | 9480 / 144840 (6.5%) | −122.6 | −120.5 | 0.33 |
| MEAF6 DRX234811 | 293 Kidney | 1351 / 14484 (9.3%) | 6417 / 144840 (4.4%) | −122.6 | −120.5 | 2.11 |
| GATA3 SRX6712581 | MCF-7 Breast | 275 / 14484 (1.9%) | 8816 / 144840 (6.1%) | −122.3 | −120.2 | 0.31 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 592 / 14484 (4.1%) | 13651 / 144840 (9.4%) | −122.2 | −120.2 | 0.43 |
| ESR1 SRX10365532 | MCF-7 Breast | 181 / 14484 (1.2%) | 7186 / 144840 (5.0%) | −122.2 | −120.2 | 0.25 |
| FOXA1 SRX028635 | MCF-7 Breast | 162 / 14484 (1.1%) | 6839 / 144840 (4.7%) | −122.2 | −120.2 | 0.24 |
| NR3C1 SRX17639412 | A549 Lung | 369 / 14484 (2.5%) | 10320 / 144840 (7.1%) | −122.1 | −120.0 | 0.36 |
| ESR1 SRX1012629 | MCF-7 Breast | 210 / 14484 (1.4%) | 7695 / 144840 (5.3%) | −121.9 | −119.9 | 0.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 164 / 14484 (1.1%) | 6869 / 144840 (4.7%) | −121.9 | −119.8 | 0.24 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 456 / 14484 (3.1%) | 11643 / 144840 (8.0%) | −121.8 | −119.8 | 0.39 |
| FOXA1 SRX5323843 | MCF-7 Breast | 166 / 14484 (1.1%) | 6900 / 144840 (4.8%) | −121.8 | −119.7 | 0.24 |
| FOXA1 SRX3923516 | MCF-7 Breast | 240 / 14484 (1.7%) | 8208 / 144840 (5.7%) | −121.7 | −119.7 | 0.29 |
| FOS SRX3322637 | MCF-7 Breast | 169 / 14484 (1.2%) | 6951 / 144840 (4.8%) | −121.7 | −119.7 | 0.24 |
| FOXA1 SRX11222438 | MCF-7 Breast | 173 / 14484 (1.2%) | 7023 / 144840 (4.8%) | −121.6 | −119.5 | 0.25 |
| MEAF6 DRX300417 | 293 Kidney | 1244 / 14484 (8.6%) | 5707 / 144840 (3.9%) | −121.5 | −119.5 | 2.18 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 772 / 14484 (5.3%) | 16132 / 144840 (11.1%) | −121.3 | −119.2 | 0.48 |
| SS18 SRX3468047 | Fibroblasts Others | 846 / 14484 (5.8%) | 17132 / 144840 (11.8%) | −121.1 | −119.1 | 0.49 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 524 / 14484 (3.6%) | 12627 / 144840 (8.7%) | −121.1 | −119.1 | 0.41 |
| NANOG SRX10445309 | Neural crest cells Neural | 175 / 14484 (1.2%) | 7042 / 144840 (4.9%) | −121.0 | −118.9 | 0.25 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 577 / 14484 (4.0%) | 13384 / 144840 (9.2%) | −120.9 | −118.9 | 0.43 |
| 5-mC SRX882965 | LNCAP Prostate | 1876 / 14484 (13.0%) | 10273 / 144840 (7.1%) | −120.8 | −118.8 | 1.83 |
| FOXA1 SRX3923517 | MCF-7 Breast | 238 / 14484 (1.6%) | 8142 / 144840 (5.6%) | −120.8 | −118.8 | 0.29 |
| EP300 SRX2194266 | SUM 159PT Breast | 588 / 14484 (4.1%) | 13538 / 144840 (9.3%) | −120.8 | −118.7 | 0.43 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 647 / 14484 (4.5%) | 14375 / 144840 (9.9%) | −120.7 | −118.7 | 0.45 |
| ESR1 SRX20282938 | MCF-7 Breast | 275 / 14484 (1.9%) | 8748 / 144840 (6.0%) | −120.4 | −118.3 | 0.31 |
| JUN SRX6582171 | GM07492 Others | 666 / 14484 (4.6%) | 14622 / 144840 (10.1%) | −120.3 | −118.3 | 0.46 |
| JUNB SRX10119384 | MCF 10A Breast | 202 / 14484 (1.4%) | 7498 / 144840 (5.2%) | −120.2 | −118.1 | 0.27 |
| ESR1 SRX1012632 | MCF-7 Breast | 162 / 14484 (1.1%) | 6773 / 144840 (4.7%) | −120.1 | −118.1 | 0.24 |
| FOXA1 SRX3931054 | MCF-7 Breast | 323 / 14484 (2.2%) | 9524 / 144840 (6.6%) | −120.1 | −118.1 | 0.34 |
| ESR1 SRX330070 | MCF-7 Breast | 171 / 14484 (1.2%) | 6941 / 144840 (4.8%) | −120.1 | −118.0 | 0.25 |
| FOXA1 SRX6878603 | LNCAP Prostate | 379 / 14484 (2.6%) | 10392 / 144840 (7.2%) | −119.7 | −117.7 | 0.36 |
| TFAP2C SRX018833 | MCF-7 Breast | 306 / 14484 (2.1%) | 9221 / 144840 (6.4%) | −119.3 | −117.3 | 0.33 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 461 / 14484 (3.2%) | 11621 / 144840 (8.0%) | −119.2 | −117.2 | 0.40 |
| FOXA1 SRX3931055 | MCF-7 Breast | 292 / 14484 (2.0%) | 8990 / 144840 (6.2%) | −119.2 | −117.2 | 0.32 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 501 / 14484 (3.5%) | 12206 / 144840 (8.4%) | −119.0 | −117.0 | 0.41 |
| TEAD3 SRX2636153 | Hep G2 Liver | 809 / 14484 (5.6%) | 16536 / 144840 (11.4%) | −118.9 | −116.9 | 0.49 |
| FOXA1 SRX1961157 | T-47D Breast | 370 / 14484 (2.6%) | 10221 / 144840 (7.1%) | −118.9 | −116.9 | 0.36 |
| PROX1 SRX3230397 | Hep G2 Liver | 246 / 14484 (1.7%) | 8217 / 144840 (5.7%) | −118.8 | −116.8 | 0.30 |
| EP300 SRX2194265 | SUM 159PT Breast | 540 / 14484 (3.7%) | 12762 / 144840 (8.8%) | −118.7 | −116.7 | 0.42 |
| ESR1 SRX5323871 | MCF-7 Breast | 373 / 14484 (2.6%) | 10260 / 144840 (7.1%) | −118.7 | −116.7 | 0.36 |
| EP300 SRX1012644 | MCF-7 Breast | 148 / 14484 (1.0%) | 6464 / 144840 (4.5%) | −118.6 | −116.5 | 0.23 |
| FOXA2 SRX100448 | Hep G2 Liver | 379 / 14484 (2.6%) | 10343 / 144840 (7.1%) | −118.4 | −116.4 | 0.37 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 165 / 14484 (1.1%) | 6780 / 144840 (4.7%) | −118.4 | −116.4 | 0.24 |
| EP300 SRX176885 | MCF-7 Breast | 173 / 14484 (1.2%) | 6922 / 144840 (4.8%) | −118.3 | −116.3 | 0.25 |
| GATAD2A SRX2636507 | Hep G2 Liver | 368 / 14484 (2.5%) | 10169 / 144840 (7.0%) | −118.2 | −116.2 | 0.36 |
| RNF2 SRX18954719 | SCC-25 Others | 460 / 14484 (3.2%) | 11569 / 144840 (8.0%) | −118.2 | −116.2 | 0.40 |
| TFAP2C SRX128099 | MCF-7 Breast | 308 / 14484 (2.1%) | 9212 / 144840 (6.4%) | −118.0 | −116.0 | 0.33 |
| ESR1 SRX10365533 | MCF-7 Breast | 158 / 14484 (1.1%) | 6634 / 144840 (4.6%) | −117.9 | −115.9 | 0.24 |
| FOXA1 SRX15430999 | T-47D Breast | 387 / 14484 (2.7%) | 10447 / 144840 (7.2%) | −117.8 | −115.8 | 0.37 |
| ESR1 SRX1469949 | MCF-7 Breast | 194 / 14484 (1.3%) | 7284 / 144840 (5.0%) | −117.8 | −115.8 | 0.27 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 216 / 14484 (1.5%) | 7668 / 144840 (5.3%) | −117.8 | −115.8 | 0.28 |
| FOXA1 SRX1961158 | T-47D Breast | 335 / 14484 (2.3%) | 9628 / 144840 (6.6%) | −117.6 | −115.6 | 0.35 |
| SSRP1 SRX3436567 | HT-1080 Bone | 322 / 14484 (2.2%) | 513 / 144840 (0.4%) | −117.3 | −115.3 | 6.28 |
| PBX3 SRX190343 | SK-N-SH Neural | 718 / 14484 (5.0%) | 15219 / 144840 (10.5%) | −117.2 | −115.2 | 0.47 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 849 / 14484 (5.9%) | 16995 / 144840 (11.7%) | −117.1 | −115.1 | 0.50 |
| ESR1 SRX1012633 | MCF-7 Breast | 176 / 14484 (1.2%) | 6931 / 144840 (4.8%) | −117.0 | −115.0 | 0.25 |
| ESR1 SRX3123829 | MCF-7 Breast | 197 / 14484 (1.4%) | 7301 / 144840 (5.0%) | −116.8 | −114.8 | 0.27 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 599 / 14484 (4.1%) | 13533 / 144840 (9.3%) | −116.7 | −114.7 | 0.44 |
| FOXA1 SRX5323829 | T-47D Breast | 188 / 14484 (1.3%) | 7138 / 144840 (4.9%) | −116.7 | −114.7 | 0.26 |
| CEBPA SRX2630241 | Hep G2 Liver | 418 / 14484 (2.9%) | 10880 / 144840 (7.5%) | −116.7 | −114.7 | 0.38 |
| ESR1 SRX5323878 | MCF-7 Breast | 344 / 14484 (2.4%) | 9732 / 144840 (6.7%) | −116.6 | −114.7 | 0.35 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 410 / 14484 (2.8%) | 10747 / 144840 (7.4%) | −116.5 | −114.5 | 0.38 |
| ESR1 SRX330069 | MCF-7 Breast | 214 / 14484 (1.5%) | 7588 / 144840 (5.2%) | −116.5 | −114.5 | 0.28 |
| FOXA2 SRX10475773 | Hep G2 Liver | 420 / 14484 (2.9%) | 10895 / 144840 (7.5%) | −116.3 | −114.3 | 0.39 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 328 / 14484 (2.3%) | 9467 / 144840 (6.5%) | −116.3 | −114.3 | 0.35 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 712 / 14484 (4.9%) | 2434 / 144840 (1.7%) | −116.2 | −114.2 | 2.93 |
| FOXA1 SRX1787651 | MCF-7 Breast | 197 / 14484 (1.4%) | 7278 / 144840 (5.0%) | −116.1 | −114.1 | 0.27 |
| FOXA1 SRX1787655 | MCF-7 Breast | 172 / 14484 (1.2%) | 6833 / 144840 (4.7%) | −116.0 | −114.1 | 0.25 |
| NR3C1 SRX8520802 | HCC1187 Breast | 259 / 14484 (1.8%) | 8338 / 144840 (5.8%) | −116.0 | −114.0 | 0.31 |
| SOX5 SRX2636544 | Hep G2 Liver | 347 / 14484 (2.4%) | 9753 / 144840 (6.7%) | −115.8 | −113.9 | 0.36 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 660 / 14484 (4.6%) | 2145 / 144840 (1.5%) | −115.8 | −113.8 | 3.08 |
| Epitope tags DRX443510 | 293 Kidney | 1165 / 14484 (8.0%) | 5295 / 144840 (3.7%) | −115.8 | −113.8 | 2.20 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 219 / 14484 (1.5%) | 7650 / 144840 (5.3%) | −115.7 | −113.7 | 0.29 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 606 / 14484 (4.2%) | 13569 / 144840 (9.4%) | −115.2 | −113.2 | 0.45 |
| FOXA1 SRX1447317 | MCF-7 Breast | 228 / 14484 (1.6%) | 7778 / 144840 (5.4%) | −114.9 | −113.0 | 0.29 |
| GATA3 SRX100559 | T-47D Breast | 383 / 14484 (2.6%) | 10275 / 144840 (7.1%) | −114.8 | −112.8 | 0.37 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 300 / 14484 (2.1%) | 8952 / 144840 (6.2%) | −114.3 | −112.4 | 0.34 |
| JUND SRX190357 | SK-N-SH Neural | 445 / 14484 (3.1%) | 11194 / 144840 (7.7%) | −114.3 | −112.3 | 0.40 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 862 / 14484 (6.0%) | 17039 / 144840 (11.8%) | −114.2 | −112.3 | 0.51 |
| ARID5B SRX10475138 | Hep G2 Liver | 576 / 14484 (4.0%) | 13102 / 144840 (9.0%) | −114.2 | −112.3 | 0.44 |
| AR SRX1067066 | LHSAR Prostate | 727 / 14484 (5.0%) | 15214 / 144840 (10.5%) | −114.2 | −112.2 | 0.48 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 291 / 14484 (2.0%) | 8802 / 144840 (6.1%) | −114.2 | −112.2 | 0.33 |
| CEBPB SRX190345 | MCF-7 Breast | 267 / 14484 (1.8%) | 8408 / 144840 (5.8%) | −114.2 | −112.2 | 0.32 |
| WWTR1 SRX10119378 | MCF 10A Breast | 383 / 14484 (2.6%) | 10250 / 144840 (7.1%) | −114.1 | −112.2 | 0.37 |
| ESR1 SRX8537723 | MCF-7 Breast | 285 / 14484 (2.0%) | 8703 / 144840 (6.0%) | −114.1 | −112.2 | 0.33 |
| RNF2 SRX18954702 | FaDu Others | 779 / 14484 (5.4%) | 15921 / 144840 (11.0%) | −114.1 | −112.1 | 0.49 |
| ARID1A SRX5089391 | MCF-7 Breast | 191 / 14484 (1.3%) | 7105 / 144840 (4.9%) | −113.9 | −112.0 | 0.27 |
| RNF2 SRX18954704 | FaDu Others | 817 / 14484 (5.6%) | 16423 / 144840 (11.3%) | −113.8 | −111.9 | 0.50 |
| MITF SRX7368255 | Hermes 3C Epidermis | 981 / 14484 (6.8%) | 18588 / 144840 (12.8%) | −113.6 | −111.7 | 0.53 |
| FOXA1 SRX3923518 | MCF-7 Breast | 244 / 14484 (1.7%) | 8009 / 144840 (5.5%) | −113.6 | −111.6 | 0.30 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 287 / 14484 (2.0%) | 8713 / 144840 (6.0%) | −113.6 | −111.6 | 0.33 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 232 / 14484 (1.6%) | 7802 / 144840 (5.4%) | −113.5 | −111.6 | 0.30 |
| Epitope tags SRX5877912 | U2OS Bone | 1887 / 14484 (13.0%) | 29795 / 144840 (20.6%) | −113.3 | −111.4 | 0.63 |
| FOSL2 SRX190296 | SK-N-SH Neural | 475 / 14484 (3.3%) | 11596 / 144840 (8.0%) | −113.1 | −111.1 | 0.41 |
| ESR1 SRX1531796 | MCF-7 Breast | 190 / 14484 (1.3%) | 7056 / 144840 (4.9%) | −113.0 | −111.0 | 0.27 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1540 / 14484 (10.6%) | 8004 / 144840 (5.5%) | −112.8 | −110.9 | 1.92 |
| FOXA1 SRX100477 | Hep G2 Liver | 403 / 14484 (2.8%) | 10502 / 144840 (7.3%) | −112.6 | −110.7 | 0.38 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1447 / 14484 (10.0%) | 7341 / 144840 (5.1%) | −112.5 | −110.6 | 1.97 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 368 / 14484 (2.5%) | 9961 / 144840 (6.9%) | −112.5 | −110.5 | 0.37 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 315 / 14484 (2.2%) | 9124 / 144840 (6.3%) | −112.3 | −110.4 | 0.35 |
| EP300 SRX22550927 | CDS1 Bone | 533 / 14484 (3.7%) | 12409 / 144840 (8.6%) | −112.2 | −110.3 | 0.43 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1253 / 14484 (8.7%) | 5979 / 144840 (4.1%) | −112.1 | −110.2 | 2.10 |
| NFYB SRX16608147 | HeLa Uterus | 212 / 14484 (1.5%) | 182 / 144840 (0.1%) | −112.1 | −110.1 | 11.65 |
| ESR1 SRX20282959 | MCF-7 Breast | 148 / 14484 (1.0%) | 6266 / 144840 (4.3%) | −112.0 | −110.0 | 0.24 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 435 / 14484 (3.0%) | 10951 / 144840 (7.6%) | −111.8 | −109.9 | 0.40 |
| AR SRX15946405 | MDA-MB-453 Breast | 229 / 14484 (1.6%) | 7691 / 144840 (5.3%) | −111.6 | −109.7 | 0.30 |
| KMT2A SRX2323891 | 293 Kidney | 788 / 14484 (5.4%) | 2950 / 144840 (2.0%) | −111.6 | −109.7 | 2.67 |
| FOXA1 SRX3923519 | MCF-7 Breast | 219 / 14484 (1.5%) | 7514 / 144840 (5.2%) | −111.6 | −109.6 | 0.29 |
| ARID1A SRX5089382 | MCF-7 Breast | 250 / 14484 (1.7%) | 8038 / 144840 (5.5%) | −111.5 | −109.6 | 0.31 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 544 / 14484 (3.8%) | 12534 / 144840 (8.7%) | −111.5 | −109.5 | 0.43 |
| FOSL2 SRX190204 | A549 Lung | 357 / 14484 (2.5%) | 9751 / 144840 (6.7%) | −111.4 | −109.5 | 0.37 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 508 / 14484 (3.5%) | 12009 / 144840 (8.3%) | −111.3 | −109.4 | 0.42 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 308 / 14484 (2.1%) | 8974 / 144840 (6.2%) | −111.3 | −109.4 | 0.34 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 241 / 14484 (1.7%) | 7879 / 144840 (5.4%) | −111.3 | −109.4 | 0.31 |
| AR SRX11149848 | MDA-MB-453 Breast | 231 / 14484 (1.6%) | 7701 / 144840 (5.3%) | −111.0 | −109.1 | 0.30 |
| STAT3 SRX5323860 | MCF-7 Breast | 444 / 14484 (3.1%) | 11048 / 144840 (7.6%) | −110.8 | −108.9 | 0.40 |
| DPF2 SRX3927297 | MOLM-13 Blood | 418 / 14484 (2.9%) | 10653 / 144840 (7.4%) | −110.7 | −108.8 | 0.39 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1384 / 14484 (9.6%) | 6937 / 144840 (4.8%) | −110.6 | −108.7 | 2.00 |
| BRD4 SRX3031983 | MV-4-11 Blood | 485 / 14484 (3.3%) | 11644 / 144840 (8.0%) | −110.6 | −108.6 | 0.42 |
| LEO1 SRX1873456 | SEM Blood | 1145 / 14484 (7.9%) | 5272 / 144840 (3.6%) | −110.5 | −108.6 | 2.17 |
| CDK9 SRX7366781 | MCF-7 Breast | 187 / 14484 (1.3%) | 125 / 144840 (0.1%) | −110.4 | −108.5 | 14.96 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 239 / 14484 (1.7%) | 7814 / 144840 (5.4%) | −110.4 | −108.5 | 0.31 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 579 / 14484 (4.0%) | 12989 / 144840 (9.0%) | −110.3 | −108.4 | 0.45 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 500 / 14484 (3.5%) | 11851 / 144840 (8.2%) | −110.3 | −108.4 | 0.42 |
| TLE3 SRX4815194 | SUM 149PT Breast | 281 / 14484 (1.9%) | 8504 / 144840 (5.9%) | −110.2 | −108.3 | 0.33 |
| SS18 SRX10881848 | G-401 Kidney | 475 / 14484 (3.3%) | 11481 / 144840 (7.9%) | −110.1 | −108.2 | 0.41 |
| AR SRX9109109 | MDA-MB-453 Breast | 418 / 14484 (2.9%) | 10624 / 144840 (7.3%) | −109.9 | −108.0 | 0.39 |
| HMG20A SRX2630163 | Hep G2 Liver | 201 / 14484 (1.4%) | 7142 / 144840 (4.9%) | −109.6 | −107.7 | 0.28 |
| KMT2C SRX1787675 | MCF-7 Breast | 311 / 14484 (2.1%) | 8963 / 144840 (6.2%) | −109.6 | −107.6 | 0.35 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 374 / 14484 (2.6%) | 9940 / 144840 (6.9%) | −109.4 | −107.5 | 0.38 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 136 / 14484 (0.9%) | 5961 / 144840 (4.1%) | −109.4 | −107.5 | 0.23 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 245 / 14484 (1.7%) | 7879 / 144840 (5.4%) | −109.3 | −107.3 | 0.31 |
| ESR1 SRX5323877 | MCF-7 Breast | 280 / 14484 (1.9%) | 8449 / 144840 (5.8%) | −109.2 | −107.3 | 0.33 |
| Epitope tags SRX15939724 | RD Muscle | 314 / 14484 (2.2%) | 8994 / 144840 (6.2%) | −109.1 | −107.2 | 0.35 |
| ESR1 SRX10365558 | MCF-7 Breast | 251 / 14484 (1.7%) | 7972 / 144840 (5.5%) | −109.1 | −107.2 | 0.31 |
| ESR1 SRX1469951 | MCF-7 Breast | 187 / 14484 (1.3%) | 6880 / 144840 (4.8%) | −109.1 | −107.2 | 0.27 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 318 / 14484 (2.2%) | 9052 / 144840 (6.2%) | −109.0 | −107.1 | 0.35 |
| FOXA1 SRX190181 | A549 Lung | 263 / 14484 (1.8%) | 8161 / 144840 (5.6%) | −108.9 | −107.0 | 0.32 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 613 / 14484 (4.2%) | 1975 / 144840 (1.4%) | −108.8 | −106.9 | 3.10 |
| EP300 SRX1012643 | MCF-7 Breast | 128 / 14484 (0.9%) | 5789 / 144840 (4.0%) | −108.7 | −106.8 | 0.22 |
| FOXA1 SRX3923515 | MCF-7 Breast | 205 / 14484 (1.4%) | 7182 / 144840 (5.0%) | −108.7 | −106.8 | 0.29 |
| EP300 SRX2671813 | Fibroblasts Others | 314 / 14484 (2.2%) | 8976 / 144840 (6.2%) | −108.6 | −106.7 | 0.35 |
| ESR1 SRX4451213 | MCF-7 Breast | 370 / 14484 (2.6%) | 9848 / 144840 (6.8%) | −108.6 | −106.7 | 0.38 |
| NR3C1 SRX2609664 | HASM2 Lung | 510 / 14484 (3.5%) | 11931 / 144840 (8.2%) | −108.6 | −106.7 | 0.43 |
| MECOM SRX23677885 | HNT-34 Blood | 1397 / 14484 (9.6%) | 7083 / 144840 (4.9%) | −108.6 | −106.7 | 1.97 |
| FOXL2 SRX6957431 | KGN Gonad | 818 / 14484 (5.6%) | 16202 / 144840 (11.2%) | −108.5 | −106.6 | 0.50 |
| RUNX1 SRX2014504 | Jurkat Blood | 1921 / 14484 (13.3%) | 10999 / 144840 (7.6%) | −108.4 | −106.5 | 1.75 |
| RXRB SRX2636027 | Hep G2 Liver | 391 / 14484 (2.7%) | 10161 / 144840 (7.0%) | −108.4 | −106.5 | 0.38 |
| NR3C1 SRX19024866 | MCF-7 Breast | 125 / 14484 (0.9%) | 5719 / 144840 (3.9%) | −108.4 | −106.5 | 0.22 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 466 / 14484 (3.2%) | 11282 / 144840 (7.8%) | −108.4 | −106.5 | 0.41 |
| MITF SRX1555436 | 501A Epidermis | 1549 / 14484 (10.7%) | 8194 / 144840 (5.7%) | −108.4 | −106.5 | 1.89 |
| ESR1 SRX1012628 | MCF-7 Breast | 187 / 14484 (1.3%) | 6858 / 144840 (4.7%) | −108.4 | −106.5 | 0.27 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 984 / 14484 (6.8%) | 4245 / 144840 (2.9%) | −108.2 | −106.4 | 2.32 |
| CEBPA SRX4705113 | MOLM-13 Blood | 819 / 14484 (5.7%) | 16203 / 144840 (11.2%) | −108.2 | −106.3 | 0.51 |
| ESR1 SRX2912055 | MCF-7 Breast | 141 / 14484 (1.0%) | 6017 / 144840 (4.2%) | −108.2 | −106.3 | 0.23 |
| FOXA1 SRX13814018 | 5637 Others | 229 / 14484 (1.6%) | 7571 / 144840 (5.2%) | −108.2 | −106.3 | 0.30 |
| FOS SRX070879 | HUVEC Cardiovascular | 390 / 14484 (2.7%) | 10135 / 144840 (7.0%) | −108.2 | −106.3 | 0.38 |
| FOXA3 SRX2630190 | Hep G2 Liver | 302 / 14484 (2.1%) | 8767 / 144840 (6.1%) | −108.1 | −106.3 | 0.34 |
| GFP SRX6949256 | HeLa Uterus | 404 / 14484 (2.8%) | 10343 / 144840 (7.1%) | −108.1 | −106.2 | 0.39 |
| FOXA1 SRX1161205 | T-47D Breast | 190 / 14484 (1.3%) | 6885 / 144840 (4.8%) | −107.6 | −105.8 | 0.28 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 127 / 14484 (0.9%) | 5738 / 144840 (4.0%) | −107.6 | −105.7 | 0.22 |
| ESR1 SRX5323872 | MCF-7 Breast | 363 / 14484 (2.5%) | 9703 / 144840 (6.7%) | −107.5 | −105.6 | 0.37 |
| CEBPB SRX190308 | HCT 116 Digestive tract | 333 / 14484 (2.3%) | 9228 / 144840 (6.4%) | −107.3 | −105.4 | 0.36 |
| CDK9 SRX7366783 | MCF-7 Breast | 189 / 14484 (1.3%) | 139 / 144840 (0.1%) | −107.2 | −105.4 | 13.60 |
| FOXA1 SRX5203303 | MCF-7 Breast | 124 / 14484 (0.9%) | 5663 / 144840 (3.9%) | −107.1 | −105.3 | 0.22 |
| FOXA1 SRX3931033 | MCF-7 Breast | 236 / 14484 (1.6%) | 7651 / 144840 (5.3%) | −107.0 | −105.1 | 0.31 |
| JUND SRX190303 | HCT 116 Digestive tract | 450 / 14484 (3.1%) | 10992 / 144840 (7.6%) | −106.9 | −105.1 | 0.41 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 258 / 14484 (1.8%) | 8007 / 144840 (5.5%) | −106.8 | −104.9 | 0.32 |
| BMI1 SRX7196721 | SF8628 Neural | 1345 / 14484 (9.3%) | 6757 / 144840 (4.7%) | −106.7 | −104.9 | 1.99 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 209 / 14484 (1.4%) | 7185 / 144840 (5.0%) | −106.7 | −104.8 | 0.29 |
| RNF2 SRX18954706 | SCC-25 Others | 449 / 14484 (3.1%) | 10965 / 144840 (7.6%) | −106.7 | −104.8 | 0.41 |
| FOXA1 SRX1447316 | MCF-7 Breast | 155 / 14484 (1.1%) | 6228 / 144840 (4.3%) | −106.6 | −104.7 | 0.25 |
| FOXA1 SRX9604647 | LNCAP Prostate | 553 / 14484 (3.8%) | 12466 / 144840 (8.6%) | −106.6 | −104.7 | 0.44 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 280 / 14484 (1.9%) | 8357 / 144840 (5.8%) | −106.5 | −104.6 | 0.34 |
| FOSL2 SRX190224 | MCF-7 Breast | 132 / 14484 (0.9%) | 5794 / 144840 (4.0%) | −106.4 | −104.6 | 0.23 |
| JUN SRX6582163 | BJ-5ta Epidermis | 463 / 14484 (3.2%) | 11157 / 144840 (7.7%) | −106.4 | −104.5 | 0.41 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 99 / 14484 (0.7%) | 5146 / 144840 (3.6%) | −106.3 | −104.5 | 0.19 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 258 / 14484 (1.8%) | 7989 / 144840 (5.5%) | −106.2 | −104.4 | 0.32 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 156 / 14484 (1.1%) | 6233 / 144840 (4.3%) | −106.2 | −104.4 | 0.25 |
| EP300 SRX100540 | SK-N-SH Neural | 527 / 14484 (3.6%) | 12079 / 144840 (8.3%) | −106.1 | −104.3 | 0.44 |
| FOXA1 SRX6860635 | T-47D Breast | 277 / 14484 (1.9%) | 8284 / 144840 (5.7%) | −105.8 | −104.0 | 0.33 |
| FOXA1 SRX5323845 | MCF-7 Breast | 137 / 14484 (0.9%) | 5868 / 144840 (4.1%) | −105.7 | −103.8 | 0.23 |
| ESR1 SRX5534831 | MCF-7 Breast | 290 / 14484 (2.0%) | 8485 / 144840 (5.9%) | −105.6 | −103.7 | 0.34 |
| ESR1 SRX2513521 | MCF-7 Breast | 179 / 14484 (1.2%) | 6624 / 144840 (4.6%) | −105.5 | −103.6 | 0.27 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 491 / 14484 (3.4%) | 11532 / 144840 (8.0%) | −105.4 | −103.6 | 0.43 |
| ARID1A SRX5089388 | MCF-7 Breast | 188 / 14484 (1.3%) | 6775 / 144840 (4.7%) | −105.3 | −103.5 | 0.28 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 414 / 14484 (2.9%) | 990 / 144840 (0.7%) | −105.2 | −103.4 | 4.18 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 319 / 14484 (2.2%) | 8930 / 144840 (6.2%) | −105.2 | −103.3 | 0.36 |
| ESR1 SRX1012630 | MCF-7 Breast | 145 / 14484 (1.0%) | 5998 / 144840 (4.1%) | −105.1 | −103.2 | 0.24 |
| JUN SRX6582172 | Fibroblasts Others | 492 / 14484 (3.4%) | 11527 / 144840 (8.0%) | −105.0 | −103.1 | 0.43 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 244 / 14484 (1.7%) | 7712 / 144840 (5.3%) | −104.9 | −103.0 | 0.32 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 367 / 14484 (2.5%) | 9663 / 144840 (6.7%) | −104.9 | −103.0 | 0.38 |
| Epitope tags SRX20741925 | Hep G2 Liver | 627 / 14484 (4.3%) | 13437 / 144840 (9.3%) | −104.8 | −103.0 | 0.47 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 160 / 14484 (1.1%) | 81 / 144840 (0.1%) | −104.7 | −102.9 | 19.75 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 307 / 14484 (2.1%) | 8724 / 144840 (6.0%) | −104.7 | −102.8 | 0.35 |
| FOXA1 SRX219284 | LNCAP Prostate | 499 / 14484 (3.4%) | 11618 / 144840 (8.0%) | −104.6 | −102.8 | 0.43 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1400 / 14484 (9.7%) | 7208 / 144840 (5.0%) | −104.5 | −102.7 | 1.94 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 399 / 14484 (2.8%) | 10127 / 144840 (7.0%) | −104.3 | −102.5 | 0.39 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 300 / 14484 (2.1%) | 8599 / 144840 (5.9%) | −104.3 | −102.5 | 0.35 |
| JUN SRX6582164 | BJ-5ta Epidermis | 469 / 14484 (3.2%) | 11166 / 144840 (7.7%) | −104.3 | −102.4 | 0.42 |
| JUNB SRX10119385 | MCF 10A Breast | 170 / 14484 (1.2%) | 6423 / 144840 (4.4%) | −104.2 | −102.4 | 0.26 |
| ESR1 SRX330068 | MCF-7 Breast | 181 / 14484 (1.2%) | 6614 / 144840 (4.6%) | −104.1 | −102.2 | 0.27 |
| NFIL3 SRX2630334 | Hep G2 Liver | 298 / 14484 (2.1%) | 8552 / 144840 (5.9%) | −103.8 | −101.9 | 0.35 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 169 / 14484 (1.2%) | 6390 / 144840 (4.4%) | −103.7 | −101.8 | 0.26 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1423 / 14484 (9.8%) | 7401 / 144840 (5.1%) | −103.7 | −101.8 | 1.92 |
| NR3C1 SRX19024870 | MCF-7 Breast | 126 / 14484 (0.9%) | 5597 / 144840 (3.9%) | −103.7 | −101.8 | 0.23 |
| SP1 SRX190269 | A549 Lung | 531 / 14484 (3.7%) | 12033 / 144840 (8.3%) | −103.6 | −101.8 | 0.44 |
| FOXA1 SRX5323830 | T-47D Breast | 223 / 14484 (1.5%) | 7319 / 144840 (5.1%) | −103.6 | −101.8 | 0.30 |
| ZNF219 SRX3230413 | Hep G2 Liver | 628 / 14484 (4.3%) | 13394 / 144840 (9.2%) | −103.5 | −101.6 | 0.47 |
| ZEB1 SRX13298924 | MCF-7 Breast | 180 / 14484 (1.2%) | 6574 / 144840 (4.5%) | −103.4 | −101.6 | 0.27 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 363 / 14484 (2.5%) | 9551 / 144840 (6.6%) | −103.4 | −101.6 | 0.38 |
| Epitope tags SRX20741907 | Hep G2 Liver | 487 / 14484 (3.4%) | 11389 / 144840 (7.9%) | −103.4 | −101.6 | 0.43 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 235 / 14484 (1.6%) | 7510 / 144840 (5.2%) | −103.3 | −101.5 | 0.31 |
| FOXA1 SRX190282 | A549 Lung | 265 / 14484 (1.8%) | 8005 / 144840 (5.5%) | −103.3 | −101.4 | 0.33 |
| FOXA1 SRX5323846 | MCF-7 Breast | 144 / 14484 (1.0%) | 5920 / 144840 (4.1%) | −103.2 | −101.4 | 0.24 |
| Epitope tags SRX10549778 | K-562 Blood | 859 / 14484 (5.9%) | 3534 / 144840 (2.4%) | −103.2 | −101.3 | 2.43 |
| EP300 SRX717859 | HeLa Uterus | 203 / 14484 (1.4%) | 6964 / 144840 (4.8%) | −103.1 | −101.3 | 0.29 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 525 / 14484 (3.6%) | 11926 / 144840 (8.2%) | −103.1 | −101.3 | 0.44 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 324 / 14484 (2.2%) | 8934 / 144840 (6.2%) | −103.1 | −101.3 | 0.36 |
Showing first 500 of 18577 rows.